RNS Number : 3169S CVS Group plc 07 January 2025 7 January 2025 CVS Group plc ("CVS" or the "Company") PDMR Dealing CVS, one of the UK's leading providers of integrated veterinary services, announces that it was made aware on 6 January 2025 that, as part of a dividend reinvestment plan, Joanne Shaw, Non-executive Director, purchased 14 ordinary shares of £0.002 each ("Ordinary Shares") at a price of 840.25 pence per Ordinary Share on 29 November 2024. Following this transaction, she holds a total of 1,562 Ordinary Shares, representing approximately 0.002% of the current Issued Share Capital of the Company. The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail. Contacts: CVS Group plc                                                                                                                                via Camarco Richard Fairman, CEO Scott Morrison, Company Secretary Peel Hunt LLP (Nominated Adviser & Broker)                                                                    +44 (0)20 7418 8900 Christopher Golden / James Steel / Andrew Clark / Lalit Bose Berenberg (Joint Broker)                                                                                                        +44 (0)20 3207 7800 Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser Camarco (Financial PR) Geoffrey Pelham-Lane +44 (0)7733 124 226 Ginny Pulbrook +44 (0)7961 315 138 Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END DSHEAFFKEFDSEAA